Bis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine: A novel candidate in photodynamic therapy for skin cancer models in vivo

Journal of Photochemistry and Photobiology B: Biology

Volumn 92, Issue 3, 2008, Pages 153-159

  Gayathri Devi, D ^a   Cibin, T R ^a   Ramaiah, D ^b   Abraham, Annie ^a  

^a UNIVERSITY OF KERALA   (India)

^b REGIONAL RESEARCH LABORATORY CSIR   (India)

Author keywords

DMBA; Photodynamic therapy; Photosensitizer; Skin tumor; Squaraine dye

Indexed keywords

BETA GLUCURONIDASE; BIS(3,5 DIIODO 2,4,6 TRIHYDROXYPHENYL)SQUARAINE; CASPASE 3; DIMETHYLBENZ[A]ANTHRACENE; HEXOKINASE; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; PHOTOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE; SIALIC ACID; THIOSULFATE SULFURTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME ASSAY; EXPERIMENTAL NEOPLASM; KIDNEY HOMOGENATE; LIGHT EXPOSURE; LIVER HOMOGENATE; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CANCER; TUMOR VOLUME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CASPASE 3; CYCLOBUTANES; GLUCURONIDASE; HEXOKINASE; KIDNEY; L-LACTATE DEHYDROGENASE; LIVER; MALE; MICE; N-ACETYLNEURAMINIC ACID; NEOPLASMS, EXPERIMENTAL; PEROXIDASE; PHENOLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; THIOSULFATE SULFURTRANSFERASE;

ANIMALIA; MUS;

EID: 50549095183     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2008.06.002     Document Type: Article

References (51)

1. Dougherty T.J. Photosensitizers: therapy and detection of malignant tumors. Photochem. Photobiol. 45 (1987) 879-889
2. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev. 24 (1995) 19-33
3. MacRobert A.J., and Philips D. Photodynamic therapy. Chem. Ind. (1992) 17-20
4. Kessel D. Photodynamic Therapy of Neoplastic Disease. second ed. (1990), CRC Press, Boca Raton, FL
5. Bauer T.W., Hahn S.M., Spitz F.R., Kachur A., Glastein E., and Fraker D.L. Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis. Ann. Surg. Oncol. 8 (2001) 254-259
6. Friedberg J.S., Mick R., Stevenson J., Metz J., Zhu T., Buyske J., Sterman D.H., Pass H.I., Glatstein E., and Hahn S.M. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann. Thorac. Surg. 75 (2003) 952-959
7. Litle V.R., Christie N.A., Fernando H.C., Buenaventura P.O., Ferson P.F., and Luketich J.D. Photodynamic therapy for endobronchial metastases from nonbronchogenic primaries. Ann. Thorac. Surg. 76 (2003) 370-375
8. Sanfilippo N.J., Hsi A., DeNittis A.S., Ginsberg G.G., Kochman M.L., Friedberg J.S., and Hahn S.M. Toxicity of photodynamic therapy after combined external beam radiotherapy and intraluminal brachytherapy for carcinoma of the upper aerodigestive tract. Lasers Surg. Med. 28 (2001) 278-281
9. Nathan T.R., Whitelaw D.E., Chang S.C., Lees W.R., Ripley P.M., Payne H., Jones L., Parkinson M.C., Emberton M., Gillams A.R., Mundy A.R., and Bown S.G. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J. Urol. 168 (2002) 1427-1432
10. Moan J., Peng Q., Sorensen R., Iani V., and Nesland J.M. Biophysical foundations of photodynamic therapy. Endoscopy 30 (1998) 387-391
11. Law K.Y. Squaraine chemistry: effects of structural changes on the absorption and multiple fluorescence emission of bis[4-(dimethylamino)-phenyl]squaraine and its derivatives. J. Phys. Chem. 91 (1987) 5184-5193
12. Law K.Y. Squaraine chemistry. Absorption, fluorescence emission and photophysics of unsymmetrical squaraines. J. Phys. Chem. 99 (1995) 9818-9824
13. Ramaiah D., Joy A., Chandrasekar N., Eldho N.V., Das S., and George M.V. Halogenated squaraine dyes as potential photochemotherapeutic agents. Synthesis and study of photophysical properties and quantum efficiencies of singlet oxygen generation. Photochem. Photobiol. 65 (1997) 783-790
14. Ramaiah D., Eckert I., T Arun K., Weidenfeller L., and Epe B. Squaraine dyes for photodynamic therapy: study of their cytotoxicity and genotoxicity in bacteria and mammalian cells. Photochem. Photobiol. 76 (2002) 672-677
15. Ewing M.W., Conti C.J., Kruszewski F.H., Slaga T.J., and DiGiovanni J. Tumor progression in sencar mouse as a function of initiator dose and promoter dose, duration and time. Cancer Res. 48 (1988) 7048-7054
16. Budunova I.V., Perez P., Vaden V.R., Spiegelman V.S., Slaga T.J., and Jorcano J.L. Increased expression of p50-NF-κB and constitutive activation of NF-kB transcription factors during mouse skin carcinogenesis. Oncogene 18 (1999) 7423-7431
17. Moore R.J., Owens D.M., Stamp G., Arnott C., Burke F., East N., Holdsworth H., Turner L., Rollins B., Pasparakis M., Kollias G., and Balkwill F. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med. 5 (1999) 828-831
18. Subapriya R., and Nagini S. Ethanolic neem leaf extract protects against N-methyl-N′-nitro-N-nitrosoguanidine induced gastric carcinogenesis in wistar rats. Asia Pac. J. Cancer Prev. 4 (2003) 215-223
19. Kumar P., Pai K., Pandey H.P., and Sundar S. NADH-oxidase, NADPH-oxidase and myeloperoxidase activity of visceral leishmaniasis patients. J. Med. Microbiol. 51 (2002) 832-836
20. Kawai Y., and Anno K. Mucopolysaccharide-degrading enzymes from the liver of the squid, Ommastrephes sloani pacificus. I. Hyaluronidase. Biochem. Biophys. Acta 242 (1971) 428-436
21. Sorbo B.H. Methods in Enzymology vol. 2 (1955), Academic Press, New York 334-337
22. King J. Practical Clinical Enzymology (1965), Van Nostrand Co. Ltd., London 83-93
23. Crane R.K., and Sols A. The association of hexokinase with particulate fractions of brain and other tissue homogenates. J. Biol. Chem. 203 (1953) 273-292
24. Warren L. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234 (1959) 1971-1975
25. 2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res. 60 (2000) 5995-6000
26. Steel R.G.D., Torrie J.H., and Dickey D.A. Principles and Procedures of Statistics: A Biometrical Approach. third ed. (1997), McGraw Hill, New York 201
27. Bowden G.T., Finch J., Domann F., and Krieg P. In: Mukhtar H. (Ed). Skin Cancer: Mechanism and Relevance (1995), CRC Press Inc., Boca Raton, FL 99-111
28. Hennings H., Glick A.B., Lowry D.T., Krsmanovic L.S., Sly L.M., and Yuspa S.H. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14 (1993) 2353-2358
29. Clair D.St., Zhao Y., Chaiswing L., and Oberley T. Modulation of skin tumorigenesis by SOD. Biomed. Pharmacother. 59 (2005) 209-214
30. Collins J.F., Brown J.P., Alexeeff G.V., and Salmon A.G. Potency equivalency factors for some polycyclic aromatic hydrocarbons and polycyclic aromatic hydrocarbon derivatives. Regul. Toxicol. Pharmacol. 28 (1998) 45-54
31. Gelboin H.V. Benzo (a) pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 60 (1980) 1107-1166
32. Chesis P.L., Levin D.E., Smith M.T., Ernster L., and Ames B.N. Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl. Acad. Sci. USA 81 (1984) 1696-1700
33. Kaul A., Mukherjee N., and Gangar S.C. Inhibitory effects of Azadirachta indica on DMBA-induced skin carcinogenesis in Balb/c mice. Mol. Cell. Biochem. 283 (2006) 47-55
34. Veena K., Shanthi P., and Sachdanandam P. Anticancer effect of Kalpaamruthaa on mammary carcinoma in rats with reference to glycoprotein components, lysosomal and marker enzymes. Biol. Pharm. Bull. 29 (2006) 565-569
35. Khan S., and Tisdale M.J. Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor. Int. J. Cancer 80 (1999) 444-447
36. A.K. Beena. Biochemical Effects of Mustard and Curry Leaf, Ph.D. Thesis, University of Kerala, 1996, p. 140.
37. Glode L.M., Epstein A., and Smith C.G. Reduced γ-cystathionase protein content in human malignant leukemia cell lines as measured by immunoassay with monoclonal antibody. Cancer Res. 41 (1981) 2249-2254
38. Akram J., Mahmoud A., and Hamid R.R. Rhodanese and arginase activity in normal and cancerous tissues of human breast, esophagus, stomach and lung. Arch. Irn. Med. 4 (2001) 88-92
39. Lippert M., Papadopoulos N., and Javadpour N. Role of lactate dehydrogenase isoenzymes in testicular cancer. Urology 18 (1981) 50-53
40. Engan T., and Hannisdal E. Blood analyses as prognostic factors in primary lung cancer. Acta Oncol. 29 (1990) 151-154
41. Elstorm R.L., Bauer D.E., Buzzai M., Karnauskas R., Harris M.H., Plas D.R., Zhuang H., Cinalli R.M., Alavi A., Rudin C.M., and Thompson C.B. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64 (2004) 3892-3899
42. Mathupala S.P., Rempel A., and Pedersen P.L. Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J. Biol. Chem. 276 (2001) 43407-43412
43. Sell S. Cancer-associated carbohydrates identified by monoclonal antibodies. Hum. Pathol. 10 (1990) 1003-1019
44. Selvam S., and Nagini S. Administration of the plasticizer di(2-ethylhexyl)phthalate alters glycoconjugate profile. Indian J. Physiol. Pharmacol. 39 (1995) 252-254
45. Bosmann H.B., Spataro A.C., and Myers M.W. Serum and host liver activities of glycosidases and sialyltransferases in animals bearing transplantable tumors. Res. Commun. Chem. Pathol. Pharmacol. 12 (1975) 499-512
46. Sun X.M., MacFarlane M., Zhuang J., Wolf B.B., Green D.R., and Cohen G.M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274 (1999) 5053-5060
47. Salvesen G.S., and Dixit V.M. Caspases: intracellular signaling by proteolysis. Cell 91 (1997) 443-446
48. Agarwal M.L., Clay M.E., Harvey E.J., Evans H.H., Antunez A.R., and Oleinick N.L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51 (1991) 5993-5996
49. He X.Y., Sikes R.A., Thomsen S., Chung L.W., and Jacques S.L. Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines. Photochem. Photobiol. 59 (1994) 468-473
50. Zaidi S.I., Oleinick N.L., Zaim M.T., and Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem. Photobiol. 58 (1993) 771-776
51. Webber J., Luo Y., Crilly R., Fromm D., and Kessel D. An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. J. Photochem. Photobiol. B 35 (1996) 209-211